secwatch.observer — SEC 8-K summary
======================================

Issuer:     RECURSION PHARMACEUTICALS, INC. (RXRX)
CIK:        0001601830
Form:       8-K
Filed at:   2023-12-20T23:59:59+00:00
Accession:  0001601830-23-000078
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Recursion partners with Enamine to create enriched screening libraries using MatchMaker predictions on 36B compounds
--------------------------------------------------------------------------------

- Up to 100 biological targets selected; Recursion's MatchMaker predicts protein-ligand interactions across Enamine's 36B REAL Space compounds.
- Recursion will receive significant number of unique REAL compounds at no cost and preferential pricing on enriched libraries.
- Enamine may offer resulting libraries to customers; libraries co-branded under Enamine and MatchMaker trademarks.
- MatchMaker uses ML for binding predictions, more scalable than traditional docking; expedites wet-lab experiments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601830/000160183023000078/0001601830-23-000078-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601830/000160183023000078/rxrx-20231220.htm
  HTML page:      https://secwatch.observer/filing/0001601830-23-000078

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer